Related Experiment Video
Updated: Aug 8, 2026

Chick ex ovo Culture and ex ovo CAM Assay: How it Really Works
Published on: November 30, 2009
Protein kinase C activity contributes to endothelial hyperpermeability during early angiogenesis in the chick
1Department of Anatomy, Cell Biology and Injury Sciences, UMDNJ-New Jersey Medical School, Newark 07103, USA.
Insights
Protein kinase C (PKC) activity contributes to leaky blood vessels during chick embryo development. Inhibiting PKC reduces leakage, while activating it can disrupt barrier function, suggesting PKC
Area of Science:
- Developmental Biology
- Vascular Biology
- Cell Signaling
Background:
- Angiogenesis in chick chorioallantoic membrane (CAM) involves microvascular proliferation.
- Endothelial hyperpermeability characterizes neovascularization up to day 4.5, with barrier function developing by day 5.0.
- The endogenous signaling pathways driving this transient hyperpermeability are not fully understood.
Purpose of the Study:
- To investigate the role of protein kinase C (PKC) signaling in CAM endothelial barrier function.
- To determine PKC's contribution to endothelial hyperpermeability during angiogenesis.
- To correlate PKC activity with the development of restrictive barrier function.
Main Methods:
- Utilized chick chorioallantoic membrane (CAM) model at embryonic days 4.5 and 5.0.
- Assessed macromolecular extravasation using FITC-dextran 40.
- Employed specific PKC inhibitors (calphostin C, bisindolymaleimide) and activators (PDD, PDBu).
Main Results:
- Inhibition of PKC with calphostin C significantly reduced FITC-dextran 40 extravasation at day 4.5.
- Selective PKC isoform inhibition also decreased extravasation, though to a lesser extent.
- PKC activation at day 5.0 partially impaired barrier properties, increasing extravasation without gap formation.
Conclusions:
- PKC activity is a contributing factor to endothelial hyperpermeability in the developing CAM vasculature.
- Down-regulation of PKC signaling is temporally associated with the establishment of a restrictive endothelial barrier.
- PKC represents a potential therapeutic target for modulating vascular permeability during angiogenesis.
Abstract:
During angiogenesis in the chick chorioallantoic membrane (CAM), microvascular proliferation continues through day 12 of the 18-day CAM lifespan. Up to day 4.5, the neovascularization is associated with endothelial hyperpermeability and differentiation of restrictive barrier function occurs abruptly at day 5.0. Although exogenous activation of cAMP/protein kinase A (PKA) signaling served to decrease macromolecular extravasation at day 4.5, endogenous signaling cascades responsible for the temporal hyperpermeability remain uncertain. Here, we evaluated protein kinase C (PKC) function in the CAM endothelium at day 4.5 and day 5.0. The specific, broad-based PKC inhibitor calphostin C reduced basal levels of FITC-dextran 40 extravasation at day 4.5. Bisindolymaleimide (BIM), which inhibits selective PKC isoforms, also reduced temporal FITC-dextran 40 efflux, but to a lesser extent than calphostin C. Activation of PKC activity by phorbol-12, 13-didecanoate (PDD) or phorbol-12, 13-dibutyrate (PDBu) at day 5.0 served to partially de-differentiate barrier properties of the angiogenic endothelium. The associated elevation of FITC-dextran 40 extravasation occurred without interendothelial gap formation along the junctional clefts. Together, these results are consistent with the interpretation that PKC activity contributes, in part, to CAM endothelial hyperpermeability at day 4.5. Furthermore, down-regulation of PKC signaling correlates temporally with the ontogeny of restrictive barrier function at day 5.0.
Related Concept Videos
Mechanism of Angiogenesis
Regulation of Angiogenesis and Blood Supply
PI3K/mTOR/AKT Signaling Pathway
cAMP-dependent Protein Kinase Pathways
Overview of Cell-Matrix Interactions
Intracellular Signaling Affects Focal Adhesions
Some...

